By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Eleven Biotherapeutics 



Cambridge  Massachusetts    U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Eleven Biotherapeutics (EBIO) Reports Second Quarter 2015 Financial Results 8/13/2015 9:32:48 AM
Eleven Biotherapeutics (EBIO) Announces First Patients Dosed With EBI-005 In Phase 3 Study In Patients With Moderate To Severe Allergic Conjunctivitis 8/12/2015 9:50:24 AM
Eleven Biotherapeutics (EBIO) To Report Second Quarter 2015 Financial Results On August 13, 2015 8/4/2015 10:52:24 AM
Eleven Biotherapeutics (EBIO) CFO Decamps for Aegerion (AEGR) in Executive Suite Shuffle 6/25/2015 8:28:49 AM
Eleven Biotherapeutics (EBIO) Announces Top-Line Results From Pivotal Phase 3 Study Of EBI-005 In Patients With Moderate To Severe Dry Eye Disease 5/18/2015 6:15:46 AM
Eleven Biotherapeutics (EBIO) Stock Nosedives 80% Premarket as Eye Drug Flunks Phase III Test 5/18/2015 6:14:51 AM
Eleven Biotherapeutics (EBIO) Presents Clinical Data On EBI-005 For The Treatment Of Dry Eye Disease And Allergic Conjunctivitis At Association for Research in Vision & Ophthalmology 2015 Annual Meeting 5/8/2015 10:17:38 AM
Eleven Biotherapeutics (EBIO) Presents Data On EBI-031 For The Treatment Of Diabetic Macular Edema At Association for Research in Vision & Ophthalmology 2015 Annual Meeting 5/6/2015 9:57:07 AM
Eleven Biotherapeutics (EBIO) Reports First Quarter 2015 Financial Results 4/30/2015 12:40:33 PM
Eleven Biotherapeutics (EBIO) Publishes Clinical Data On EBI-005 For The Treatment Of Allergic Conjunctivitis 4/29/2015 8:19:32 AM
1234567
//-->